Cerenome Launches as an Integrated CNS Oncology Company
July 31, 2026
Palatin Announces Publication of Vyleesi® (bremelanotide) fMRI Study in Women with Hypoactive Sexual Desire Disorder (HSDD)
October 17, 2022
Related Post
-
-
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
July 31, 2026
-
SciSparc: Subsidiary NeuroThera Labs’ Quantum Platform Demonstrates Complete End-to-End Hybrid Quantum-Classical Workflow for Clinical Data Analytics
July 31, 2026
-
Tiziana Reports Reduction in Brain Inflammation in Third Multiple System Atrophy Patient Treated with Intranasal Foralumab
July 31, 2026